Celldex Therapeutics, Inc. (CLDX) vs Immunome, Inc. (IMNM)
Celldex Therapeutics, Inc. and Immunome, Inc. are both Biotechnology companies. Celldex Therapeutics, Inc. and Immunome, Inc. are of similar size ($2.6B and $2.5B). Immunome, Inc. grew revenue faster over the last twelve months: 16.7% against −88.3%. Immunome, Inc. has the higher net margin (0.00% vs −33,883.8%) and the lower return on invested capital (−3,323.0% vs 0.00%). Across the 16 metrics below, Immunome, Inc. leads on 11 and Celldex Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | CLDX | IMNM | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (36,733.82%) | 0.00% | 0.00% |
| Net margin | (33,883.77%) | 0.00% | 0.00% |
| Free cash flow margin | (27,294.81%) | 0.00% | 0.00% |
| Return on equity | (43.88%) | (64.03%) | (57.72%) |
| Return on assets | (40.76%) | (59.03%) | (49.22%) |
| Return on invested capital | 0.00% | (3,322.99%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack